Sharon Worcester, MA

News

FDA Approves First-in-Class Drug for Lower-Risk Myelodysplastic Syndromes

Author:: Sharon Worcester, MA

Publish date: June 7, 2024

The approval for the first-in-class agent is “potentially practice changing” given the lack of treatment options for transfusion-dependent, lower-r...

News

FDA Approves New Bladder Cancer Drug

Author:: Sharon Worcester, MA

Publish date: April 24, 2024

The FDA declined an initial approval for the combination in May 2023.

News

New Screening Protocol May Improve Prostate Cancer Detection

Author:: Sharon Worcester, MA

Publish date: April 23, 2024

A new trial assesses a screening intervention that aims to reduce unnecessary diagnoses of prostate cancer but still catch relevant cancers and red...

News

FDA Expands Enhertu Indication to HER2-Positive Solid Tumors

Author:: Sharon Worcester, MA

Publish date: April 9, 2024

The agent had already been approved for several cancer types.

News

New Guidelines: Start PSA Screening Earlier in Black Men

Author:: Sharon Worcester, MA

Publish date: March 22, 2024

Multidisciplinary panel suggests lowering the screening age to 40-45 for PSA testing in Black men.

News

FDA Approves New Esophageal Cancer Drug

Author:: Sharon Worcester, MA

Publish date: March 18, 2024

The approval, which was deferred in 2022 due to COVID-19-related restrictions, marks the first for the agent in the United States.

News

FDA Approves First CAR T-Cell Therapy for rrCLL, rrSLL

Author:: Sharon Worcester, MA

Publish date: March 15, 2024

For the first time, CAR T-cell therapy for treatment of relapsed/refractory CLL or SLL gets FDA approval.

News

FDA Approves Amivantamab First-line Indication for NSCLC

Author:: Sharon Worcester, MA

Publish date: March 4, 2024

The FDA also granted traditional approval for use in patients with locally advanced or metastatic NSCLC with EGFR exon 20 insertion mutations after...

News

FDA Approves First Cellular Therapy for Metastatic Melanoma

Author:: Sharon Worcester, MA

Publish date: February 20, 2024

Patients with metastatic melanoma have potential new treatment option with approval of T-cell immunotherapy.

News

Does Eliminating Alcohol Intake Lower Cancer Risk?

Author:: Sharon Worcester, MA

Publish date: February 8, 2024

There is limited evidence to support a link between eliminating or reducing alcohol consumption and lowering of cancer risk.

News

New Guidelines: Start PSA Screening Earlier in Black Men

Author:: Sharon Worcester, MA

Publish date: January 30, 2024

Baseline PSA testing in Black men should begin at age 40-45, and should be followed by regular screening intervals, preferably annually.

News

Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations

Author:: Sharon Worcester, MA

Publish date: January 25, 2024

Dana-Farber Cancer Institute retracts six papers and corrects more than 30 after data changes found.

News

Young Myeloma Specialist Forges Ahead, Gives Back

Author:: Sharon Worcester, MA

Publish date: January 25, 2024

“Manni” Mohyuddin, MD, reflects on patient needs, compassionate care, medical education, and recent advances in treating multiple myeloma.

News

CRISPR-Based Gene Therapy Earns Beta Thalassemia Approval

Author:: Sharon Worcester, MA

Publish date: January 18, 2024

Ten weeks ahead of target date, FDA greenlights this innovative treatment for a rare blood disorder.

News

Serum Hormone Concentrations May Predict Aromatase Inhibitor Benefit for BC Prevention

Author:: Sharon Worcester, MA

Publish date: December 20, 2023

Measuring estradiol, testosterone, and SHBG more widely to identify those postmenopausal women at high risk for breast cancer who would benefit fro...